Patents/Inventors

Andrew Geall

Littleton, MAUS33 patents

36 Patents

US121863332025
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US120180442024
RNA Purification Methods
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US119130012024
Immunisation of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US119055142024
Immunisation of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICAL SA
0 cites
US118966362024
Immunogenic Combination Compositions and Uses Thereof
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118916082024
Immunization of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118835342024
Immunisation with Lipid Formulations with RNA Encoding Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118650802024
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US118575622024
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US118576812024
Lipid Formulations with RNA Encoding Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118503052023
Method of Making Lipid Formulations with RNA Encoding Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118516602023
Immunisation of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118459252023
Immunisation of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US118396862023
Lipid Formulations with Viral Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117864672023
Lipid Formulations with Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117733952023
Immunization of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117664012023
Methods of Administering Lipid Formulations with Immunogens
Glaxosmithkline Biologicals SA
0 cites
US117594222023
Pegylated Liposomes for Delivery of Immunogen-encoding RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117594752023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US117393342023
Immunisation of Large Mammals with Low Doses of RNA
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117307002023
Lipid Formulations with Viral Immunogens
GLAXOSMITHKLINE BIOLOGICALS SA
0 cites
US117307542023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US117308042023
Compositions and Methods for the Prevention and Treatment of Rabies Virus Infection
Replicate Bioscience, Inc.
0 cites
US117175292023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US117074822023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116969232023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals, SA
0 cites
US116908612023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116908622023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116908632023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116908642023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116908652023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites
US116665342023
Methods of Administering Lipid Formulations with Viral Immunogens
Glaxosmithkline Biologicals SA
0 cites
US116554752023
Immunisation of Large Mammals with Low Doses of RNA
Glaxosmithkline Biologicals SA
0 cites
US116386932023
Vaccine for Eliciting Immune Response Comprising RNA Encoding an Immunogen and Lipid Formulations Comprising Mole Percentage of Lipids
Glaxosmithkline Biologicals SA
0 cites
US116386942023
Vaccine for Eliciting Immune Response Comprising Lipid Formulations and RNA Encoding Multiple Immunogens
Glaxosmithkline Biologicals SA
0 cites
US115966452023
Delivery of RNA to Trigger Multiple Immune Pathways
Glaxosmithkline Biologicals SA
0 cites